Back to Agenda
Expanding Research Participation through Local Health Care Providers: Perceptions and Strategies to Reach Communities
Session Chair(s)
Jane Myles, MSC
Program Director
Jemtech Co, United States
This session will share healthcare professionals' (HCP) perceptions about participating in clinical research as non-investigators. We will address the challenges and opportunities for HCP participation, aligned to the FDA guidance on DCTs as well as Point of Care Trials.
Learning Objective : Analyze healthcare professionals' (HCPs) perceptions, both positive and negative, about participating in clinical research; Evaluate which routine care trial assessments HCPs might conduct as part of trials and assess study fit; Identify key strategies to engage HCPs in trial participation without requiring them to become investigators
Speaker(s)
Panelist
Meghana Chalasani, MHA
FDA, United States
Associate Director for Clinical Trial Innovation, Office of New Drugs, CDER
Industry Perspective
Shelly Barnes
UCB Biosciences, United States
Global Clinical Innovations Lead
Industry Perspective
Brittany Niland
Eli Lilly and Company, United States
Senior Director-Clinical Trials Foundation Community Based Research
Have an account?